Start for free
Start for free
i&i Biotech Fund logo

i&i Biotech Fund

Europe, Luxembourg, Luxembourg, Luxembourg

Description

i&i Biotech Fund is a venture capital firm.

Investor Profile

i&i Biotech Fund has made 8 investments, with 2 in the past 12 months and 63% as lead.

Stage Focus

  • Seed (75%)
  • Series A (25%)

Country Focus

  • Czech Republic (25%)
  • The Netherlands (25%)
  • United States (13%)
  • Austria (13%)
  • Germany (13%)
  • United Kingdom (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Big Data
  • Bioinformatics
  • Health Diagnostics
  • Medical Device
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does i&i Biotech Fund frequently co-invest with?

IP
i&i Prague
Europe, Hlavni mesto Praha, Czech Republic, Praha
Co-Investments: 1
Longevitytech.fund
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 1
OostNL
OostNL
Europe, Gelderland, The Netherlands, Apeldoorn
Co-Investments: 2
Holeček Family Foundation
Co-Investments: 1
Demcon
Demcon
Europe, Overijssel, The Netherlands, Enschede
Co-Investments: 1
bpd partners
bpd partners
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 1
Formic Ventures
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Tensor Ventures
Tensor Ventures
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 2
KT
KHAN Technology Transfer Fund
Europe, Nordrhein-Westfalen, Germany, Dortmund
Co-Investments: 2
BA
Co-Investments: 1

What are some of recent deals done by i&i Biotech Fund?

Antiverse

Cardiff, Cardiff, United Kingdom

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMachine Learning
SeedOct 15, 2024
Amount Raised: $4,572,707
Captain T Cell

Berlin, Berlin, Germany

Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.

Health CareTherapeuticsWellness
SeedMay 22, 2024
Amount Raised: $9,200,897
Casinvent Pharma

Brno, Jihomoravsky kraj, Czech Republic

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

MedicalPharmaceutical
SeedJan 31, 2024
Amount Raised: $1,728,713
HeartBeat.bio

Vienna, Wien, Austria

HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.

BiotechnologyMedical
SeedNov 2, 2023
Amount Raised: $4,777,070
Delta Diagnostics

Rotterdam, Zuid-Holland, The Netherlands

Delta Diagnostics is a biotech company that creates highly sensitive and selective biosensors using integrated photonics.

Biotechnology
Series AMay 9, 2023
Amount Raised: $5,756,453
Enzyre

Nijmegen, Gelderland, The Netherlands

Enzyre is a developer of diagnostic technology.

Health CareMedical Device
Series ANov 2, 2022
Amount Raised: $11,776,679
Casinvent Pharma

Brno, Jihomoravsky kraj, Czech Republic

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

MedicalPharmaceutical
SeedSep 26, 2022
Amount Raised: $1,250,607
Sampling Human

Berkeley, California, United States

Single cell, spatial omics

Big DataBioinformaticsBiotechnologyHealth CareHealth Diagnostics
SeedApr 12, 2022
Amount Raised: $2,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator